The ONWARDS3 Clinical Trial

Is Testosterone Therapy Safe for the Heart? Insights from the TRAVERSE Study

Retatrutide Clinical Trial

Orforglipron vs. Type 2 Diabetes: A Breakthrough in Oral Treatment?

Bone Mineral Density and Turnover After Sleeve Gastrectomy and Gastric Bypass.

SURPASS-2: A Study of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

STEP 1 : Semaglutide Treatment Effect in People with Obesity

SOLOIST-WHF: Effect of Sotagliflozin on Cardiovascular Events in Patients with Type 2 Diabetes Post Worsening Heart Failure.

SCORED : Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

MOBILE : Continuous Glucose MOnitoring in T2D Basal InsuLin UsErs.

Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes

FIDELIO-DKD: Finerenone in Subjects with Type 2 Diabetes Mellitus and Diabetic Kidney Disease

EMPEROR-Preserved: EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction.

COMPASS: Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia

AMPLITUDE-O: Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.

AfterDmab: Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation.

ACTIVE : Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial

WHI E + P

AMIGOS : Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility

HERS Study

KEEPS Study : Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial

PCOS (LETROZOLE STUDY)

FET

ELITE – The Early versus Late Intervention Trial with Estradiol

PCOS

EMPA-REG OUTCOME : Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

ELIXA

EDIC

DAPS Study : Denosumab Adherence Preference Satisfaction Study

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial

FIT : Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

PTH(1-34) : Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

FRAME : Romosozumab Treatment in Postmenopausal Women with Osteoporosis

FREEDOM : Denosumab for prevention of fractures in postmenopausal women with osteoporosis

HORIZON : Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

Zoledronic Acid Recurrent Fracture Trial

PASIREOTIDE B2305 STUDY GROUP : A 12-month phase 3 study of pasireotide in Cushing’s disease

COPEPTIN – A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus

RECORD: Rosiglitazone Evaluated for Cardiovascular Outcomes in oRal agent combination therapy for type 2 Diabetes mellitus

4S : The Scandinavian Simvastatin Survival Study

JUPITER – Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

IMPROVE-IT : Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

HPS3/TIMI55 : Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

HOPE-3 Trial : Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

ASCEND : Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

CONQUER

CAMELLIA-TIMI 61 : Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

COR1

STAMPEDE : Bariatric surgery versus intensive medical therapy in obese patients with diabetes

ORIGIN N-3 Fatty Acid

ODYSSEY OUTCOMES : Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

SPRINT

SPYRAL HTN-ON MED